Resveratrol (trans-3,4',5-trihydroxystilbene) is a polyphenolic natural product with a well-known polypharmacological profile that places it among the multi-target-directed
ligands (MTDLs). Given its protective action against a wide number of
chronic diseases, in this review, we introduce a general overview about the cardioprotective and
antioxidant effects, the
antidiabetic, neuroprotective and anti-inflammatory effects of this
polyphenol. In the second part of the manuscript, we focused our attention on the anticancer activity of
Resveratrol, given the alteration of many different signaling pathways, leading to suppression of
tumor cell proliferation in numerous
cancer types. Among the several anticancer targets involved in the mechanism of action of
Resveratrol, here we introduce experimental and molecular modeling studies performed against the SGK1
protein as a novel anticancer target of
Resveratrol. SGK1 inhibitors have been demonstrated to inhibit cell growth of different
cancer cells. We demonstrated that
resveratrol inhibits SGK1 in vitro and in intact cells, affecting proliferation and survival of HUH7 human
hepatoma cells. Our findings demonstrate that
resveratrol may function as a SGK1 inhibitor, suggesting possible applications in
sodium retention and
cancer.